RPRXNasdaqGS
Royalty Pharma plc
$54.21
ListedJun 16, 2020
SectorHealthcare
IndustryBiotechnology
CountryUnited States
Employees100
StateNY| CityNew York| Address110 East 59th Street| Phone212 883 0200
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

Key Indicators

Key financial and dividend metrics for this stock.

?
P/E Ratio
28.5
?
Div. Rate
$0.94
?
Div. Yield
1.69%
?
Payout Ratio
47.11%
?
Max Consec. Div. Years
6 years
?
Longest Consec. Div.
5 years
?
Div. Coverage
100%
?
Div. Stability Rate
0.10
?
Div. Growth Rate
100.00%
?
Score
97

Dividend History

Historical dividend payments by ex-dividend date.

May 15, 2026
$ 0.2300
Feb 20, 2026
$ 0.2300
Nov 14, 2025
$ 0.2200
Aug 15, 2025
$ 0.2200
May 16, 2025
$ 0.2200
Feb 21, 2025
$ 0.2200
Nov 15, 2024
$ 0.2100
Aug 16, 2024
$ 0.2100
May 16, 2024
$ 0.2100
Feb 15, 2024
$ 0.2100
Nov 16, 2023
$ 0.2000
Aug 17, 2023
$ 0.2000
May 18, 2023
$ 0.2000
Feb 15, 2023
$ 0.2000
Nov 17, 2022
$ 0.1900
Aug 18, 2022
$ 0.1900
May 19, 2022
$ 0.1900
Feb 17, 2022
$ 0.1900
Nov 18, 2021
$ 0.1700
Aug 19, 2021
$ 0.1700
May 19, 2021
$ 0.1700
Feb 18, 2021
$ 0.1700
Nov 19, 2020
$ 0.1500
Sep 14, 2020
$ 0.1500

Peer Companies

Other stocks in the same sector.

The app download will be available in the next version. Stay tuned!